A recent meta-analysis reveals no link between pathologic complete response and long-term survival in rectal cancer, challenging its use as a surrogate endpoint.

Recent analyses have shown that da Vinci robotic surgery achieves a 99% reliability rate, with technical issues rarely ...

The surge in early-onset colorectal cancer has prompted urgent campaigns to educate the public and health care ...

A new study published in the journal of BMC Surgery showed that robotic surgery for rectal cancer exhibits oncological and ...

The Mohammed VI Foundation for Science and Health (FM6SS) achieved a milestone in robotic surgery Thursday, July 24 with the successful completion of its first robot-assisted visceral operation at ...

Cheikh Khalifa International University Hospital in Casablanca successfully carried out its first robot-assisted ...

Q2 2025 Earnings Call Transcript July 22, 2025 Intuitive Surgical, Inc. beats earnings expectations. Reported EPS is $2.19, ...

When EID yields positive resection margins, or reveals high-risk features for ... potential of EID to shift the treatment paradigm for low to intermediate-risk T1 rectal cancer and selected T2 cases, ...

Data are mixed on whether indocyanine green (ICG) fluorescence angiography can reduce the high rate of anastomotic leaks in patients undergoing surgery for rectal cancer. Therefore, we aimed to ...

A new study by a Tulane University researcher casts doubt on a widely used shortcut in rectal cancer drug trials, raising concerns that some treatments may be fast-tracked for approval without ...

A new study raises concerns about a widely used shortcut in approving rectal cancer drugs, showing that the absence of detectable tumors after treatment—known as pathologic complete response ...

Patients with locally advanced rectal cancer receive a variety of TNT regimens, but the regimens are similarly effective, data suggest.